C Eng, D Clayton, I Schuffenecker, G Lenoir, … - Jama, 1996 - Am Med Assoc OBJECTIVE: Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant
disorder. The 3 recognized subtypes include MEN 2A, characterized by medullary
thyroid carcinoma (MTC), pheochromocytoma (pheo), and hyperparathyroidism ... Cited by 531 - Related articles - All 4 versions
- ►ascopubs.org C Eng - Journal of Clinical Oncology, 1999 - jco.ascopubs.org The RET proto-oncogene, located on chromosome subband 10q11.2, encodes a
receptor tyrosine kinase expressed in tissues and tumors derived from neural
crest. Germline (present in every cell of the body) mutations in RET cause ... Cited by 225 - Related articles - BL Direct - All 8 versions
C Eng, LM Mulligan - Human mutation, 1997 - interscience.wiley.com The RET proto-oncogene codes for a receptor tyrosine kinase thought to play a
role in the development of neural crest and its derivatives. Mutations in the
RET proto-oncogene have been found in patients with the multiple endocrine ... Cited by 168 - Related articles - BL Direct - All 3 versions
C Eng - New England Journal of Medicine, 1996 - content.nejm.org Recent years have brought major advances in our understanding of the molecular
genetic basis of both types of multiple endocrine neoplasia (MEN), an autosomal
dominant cancer syndrome. MEN type 1 (MEN-1 [designated "MEN 1" by the ... Cited by 147 - Related articles - All 3 versions
- ►angrylapdog.com L Yip, GJ Cote, SE Shapiro, GD Ayers, CE … - Archives of Surgery, 2003 - archsurg.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 114 - Related articles - BL Direct - All 8 versions
DJ Marsh, DL Learoyd, BG Robinson - Thyroid, 1995 - liebertonline.com Page 1. THYROID Yolume 5, Number 5, 1995 Mary Ann Liebert, Inc. Medullary
Thyroid Carcinoma: Recent Advances and Management Update ... Cited by 105 - Related articles - BL Direct - All 2 versions
HM Heshmati, H Gharib, JA van Heerden, GW … - The American journal of medicine, 1997 - Elsevier Recent advances in the diagnosis and treatment of medullary thyroid carcinoma
(MTC) have been significant, but some issues remain controversial. MTC may occur
either as a hereditary or a nonhereditary entity. Hereditary MTC can occur ... Cited by 99 - Related articles - BL Direct - All 5 versions
- ►annals.org GA Ledger, S Khosla, NM Lindor, SN … - Annals of internal medicine, 1995 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Purpose: To review significant advances in the early diagnosis and ... Cited by 80 - Related articles - All 4 versions
S Leboulleux, E Baudin, JP Travagli, M … - Clinical Endocrinology, 2004 - sepeap.org Medullary thyroid carcinoma (MTC) arises from para- follicular or C cells that
produce calcitonin (CT), and accounts for 5–10% of all thyroid cancers. MTC is
hereditary in about 25% of cases. The discovery of a MTC in a patient has ... Cited by 76 - Related articles - View as HTML - BL Direct - All 9 versions
- ►ascopubs.org JG Guillem, WC Wood, JF Moley, A Berchuck, … - Annals of surgical oncology, 2006 - Springer Page 1. ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common
Hereditary Cancer Syndromes José G. Guillem, MD, MPH, 1 ... Cited by 73 - Related articles - BL Direct - All 16 versions
